Human Anti-D Immunoglobulin
This is a blood fraction derived from human plasma containing antibodies against the D antigen on red blood cells, used prophylactically to prevent Rh incompatibility in pregnancies. It qualifies under HTS 3002.12.00 as an antiserum and blood fraction prepared for therapeutic or prophylactic use. The product is obtained through plasma fractionation and purification processes.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If classified as an immunological product like monoclonal antibodies rather than blood fraction
Immunological products involving peptides/proteins for immune regulation fall under 3002.13, distinct from traditional antisera.
If for cell cultures or modified micro-organism cultures used in production
If the product includes cell cultures rather than direct blood fractions, it shifts to other products in the 3002 antisera grouping.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Verify FDA biologics license and provide certificates of analysis confirming purity and sterility for customs clearance
• Ensure proper cold chain documentation (2-8°C) to avoid spoilage claims and duty exemptions
• Label as 'human blood fraction' avoiding diagnostic claims to prevent reclassification under Chapter 38
Related Products under HTS 3002.12.00
Human Immunoglobulin G (IgG) Intravenous
IVIG is a pooled blood fraction from human plasma containing primarily IgG antibodies, used therapeutically for immune deficiencies and autoimmune disorders. It is classified under HTS 3002.12.00 as other blood fractions prepared for therapeutic uses via biotechnological purification. This sterile, high-purity product replaces missing antibodies in patients.
Rabies Immune Globulin (Human)
This human-derived antiserum provides passive immunity against rabies virus post-exposure, consisting of purified IgG antibodies from vaccinated donors. Classified in HTS 3002.12.00 as antisera and blood fractions for prophylactic use. It is administered intramuscularly alongside vaccine for high-risk exposures.
Tetanus Immune Globulin (Human)
A human blood fraction containing high-titer antibodies against tetanus toxin, used for passive immunization in wound management. Falls under HTS 3002.12.00 as antisera prepared for therapeutic and prophylactic purposes. It is sterile and lyophilized for intramuscular injection.
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)
CMV-IGIV is a purified immunoglobulin fraction from human plasma of donors with high CMV antibody titers, used prophylactically in transplant patients. It is classified under HTS 3002.12.00 as other blood fractions for therapeutic use. The product prevents CMV infection through passive antibody transfer.
Hepatitis B Immune Globulin (HBIG)
HBIG is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen, used for post-exposure prophylaxis. Under HTS 3002.12.00 as antisera for therapeutic and prophylactic applications. It provides immediate protection in high-risk scenarios like needlestick injuries.
Botulism Antitoxin (Trivalent, Equine)
This equine-derived antiserum neutralizes botulinum neurotoxins A, B, and E, used therapeutically for botulism poisoning. Classified in HTS 3002.12.00 as antisera prepared for therapeutic uses, including animal blood sources. It is purified to reduce hypersensitivity risks.